| # | Drug | Count |
|---|---|---|
| 0 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 9 |
| 1 | RILPIVIRINE HYDROCHLORIDE | 9 |
| 2 | RALTEGRAVIR | 8 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 4 | EMPAGLIFLOZIN | 2 |
| 5 | METRONIDAZOLE | 2 |
| 6 | METRONIDAZOLE TOPICAL | 2 |
| 7 | ACETAMINOPHEN | 1 |
| 8 | ACETAMINOPHEN 500MG | 1 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RILZABRUTINIB | 1 | 0.0018 |
| 1 | RALTEGRAVIR | 8 | 0.0015 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 9 | 0.0014 |
| 3 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 4 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| 5 | ELAGOLIX | 1 | 0.0003 |
| 6 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 7 | PRAZOSIN | 1 | 0.0002 |
| 8 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 9 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |
| 1 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0001 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 2 | 0.0000 |
| 4 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 7 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 8 | Catecholamine [EPC] | 1 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |